Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Targeted therapies for stage III non-small cell lung cancer: Integration in the combined modality setting
Everett E. Vokes,
Hak Choy
Radiation Oncology
Radiation Oncology - Administration
Research output
:
Contribution to journal
›
Article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted therapies for stage III non-small cell lung cancer: Integration in the combined modality setting'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Chemoradiotherapy
100%
Non-Small Cell Lung Carcinoma
83%
Radiotherapy
64%
Combined Modality Therapy
58%
Cyclooxygenase 2
49%
Combination Drug Therapy
47%
ErbB Receptors
44%
Lung Neoplasms
37%
Carcinogenesis
35%
Survival Rate
35%
Clinical Trials
30%
Therapeutics
15%
Neoplasms
15%